35
Participants
Start Date
May 31, 2010
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
dapagliflozin
Oral Solution, Oral, 0.001 mg, once on Day 1 only, 2 days
dapagliflozin
Oral Solution, Oral, 0.01 mg, once on Day 1 only, 2 days
dapagliflozin
Oral Solution, Oral, 0.1 mg, once on Day 1 only, 2 days
dapagliflozin
Tablets, Oral, 0.3 mg, once on Day 1 only, 2 days
dapagliflozin
Tablets, Oral, 1 mg, once on Day 1 only, 2 days
dapagliflozin
Tablets, Oral, 2.5 mg, once on Day 1 only, 2 days
Ppd Development, Lp, Austin
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY